retatrutide drug retatrutide Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate ⚠️ “RETA” is NOT an

"We're really pushing hard to get into that second position behind orforglipron, now Foundayo." Pfizer also unveiled mid-stage data from a shot it gained through its $10 billion acquisition of Metsera

Vadim Sherman, medical director of bariatric and metabolic surgery and obesity medicine specialist

Meanwhile, neurologists and addiction medicine specialists were more likely to prescribe the medications for offlabel uses

Site comparison table The takeaway is clear

The group on semaglutide only experienced 794 fractures, while the control group experienced 1,045

Among the study population, 336,655 patients with Type 2 diabetes received GLP-1RAs and 2,203,082 patients did not undergo treatment with GLP-1RAs